87313 studies found for:    United States
Show Display Options
Rank Status Study
1 Recruiting Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
Condition: Asthma
Intervention: Other: Laboratory biomarker analysis
2 Not yet recruiting Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Condition: COPD
Interventions: Drug: BGF MDI (PT010) 320/14.4/9.6 μg;   Drug: GFF MDI (PT003) 14.4/9.6 μg;   Drug: BFF MDI (PT009) 320/9.6 μg
3 Not yet recruiting Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: APD334;   Drug: Placebo
4 Recruiting Zenith® Low Profile AAA Endovascular Graft
Conditions: Abdominal Aortic Aneurysms;   Iliac Aneurysms;   Aortoiliac Aneurysms
Intervention: Device: Zenith Low Profile AAA Endovascular Graft
5 Not yet recruiting A Phase 3 Study of Tanezumab for Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Placebo to Week 16; tanezumab 5mg SC;   Biological: Placebo to Week 16, tanezumab 10 mg SC;   Biological: Tanezumab 5 mg SC;   Biological: Tanezumab 10 mg SC;   Biological: Tramadol PR oral
6 Recruiting Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Conditions: Chronic Pain;   Osteoarthritis, Hip;   Osteoarthritis, Knee
Interventions: Drug: NSAID;   Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 5 mg
7 Recruiting A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: VX-809;   Drug: Placebo;   Drug: VX-770
8 Recruiting Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
Conditions: Carcinoma, Non-Small-Cell Lung;   ErbB Receptors
Intervention: Drug: Afatinib
9 Recruiting A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Ixekizumab;   Drug: Placebo
10 Not yet recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
11 Not yet recruiting AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Condition: Stage IB-IIIA Non-small Cell Lung Carcinoma, With a Centrally Confirmed, Common Sensitising EGFR Mutations
Interventions: Drug: AZD9291 80 mg/40 mg;   Drug: Placebo AZD9291 80 mg/40 mg
12 Recruiting Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab ITV injection;   Drug: Ranibizumab through RPDS Implant
13 Not yet recruiting A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Condition: Hepatitis C Virus Infection
Interventions: Drug: Sofosbuvir (SOF);   Drug: Ledipasvir/Sofosbuvir (LDV/SOF)
14 Recruiting Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
Conditions: Opioid Use Disorder;   Opioid-related Disorders
Interventions: Drug: SUBOXONE sublingual film;   Drug: high dose RBP-6000;   Drug: low dose RBP-6000
15 Not yet recruiting Reevaluation Of Systemic Early Neuromuscular Blockade
Condition: Acute Respiratory Distress Syndrome
Intervention: Drug: cisastracurium besylate
16 Recruiting Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)
Condition: Hypogonadism
Intervention: Drug: Testosterone enanthate auto-injector
17 Recruiting A Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Condition: Chronic Kidney Disease (CKD)
Interventions: Drug: Epoetin Hospira Arm;   Other: Standard of Care Arm
18 Not yet recruiting Effects of Abatacept in Patients With Early Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Methotrexate;   Other: Abatacept Placebo;   Other: Methotrexate Placebo
19 Recruiting Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Condition: Peripheral Artery Disease
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
20 Recruiting Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Conditions: Inflammatory Bowel Disease;   Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention: Device: Stool Collection Kit

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years